Ionis Pharmaceuticals (IONS) Equity Income (2010 - 2012)

Ionis Pharmaceuticals' Equity Income history runs 3 years deep, the most recent figure standing at -$267000.0 for Q4 2012.

• In Q4 2012, Equity Income rose 79.12% year-over-year to -$267000.0; the TTM figure through Dec 2012 stood at -$1.4 million (up 60.44% YoY), while the FY2012 annual figure was -$1.4 million, up 60.44% from the prior year.
• Equity Income was -$267000.0 for Q4 2012 at Ionis Pharmaceuticals, down from -$163000.0 in the prior quarter.
• In the past five years, Equity Income ranged from a high of -$163000.0 in Q2 2012 to a low of -$3.9 million in Q2 2010.
• Historically, Equity Income has averaged -$1.1 million across 3 years, with a median of -$930000.0 in 2010.
• The sharpest annual moves came in 2011 and 2012: Equity Income sank 145.49% in 2011, then soared 84.22% in 2012.
• A 3-year view of Equity Income shows it stood at -$521000.0 in 2010, then tumbled by 145.49% to -$1.3 million in 2011, then soared by 79.12% to -$267000.0 in 2012.
• The last three Equity Income figures came in at -$267000.0 (Q4 2012), -$163000.0 (Q2 2012), and -$976000.0 (Q1 2012), per Business Quant data.